Prostate Cancer Learning Hub

Welcome to the Prostate Cancer Learning Hub

This educational resource is designed to support healthcare professionals treating prostate cancer; to better understand its risk factors, symptoms, detection and treatment options. The disease awareness education section was updated in January 2017.

STOP-6 2016 video presentations, EAU 2016 video presentations, disease awareness education and the Feel+ Support Programme link (patient resource) have been recently added.

Disease Awareness

The Disease Awareness section has been designed to provide you with the best practice guidance for the treatment and management of your patients. Updated Jan. 2017.

Figure 3. Relative survival by age at diagnosis
Learn More


CHMP recommends approval of Tookad (padeliporfin) for adenocarcinoma of the prostate.- STEBA Biotech.

Independent data monitoring committee determines that Phase III study of Prostvac in prostate cancer should...

Phase III PROSPER trial of Xtandi (enzalutamide) plus androgen deprivation therapy (ADT) versus ADT alone...

STOP-6 2016 Videos

STOP-5 Presentations

EAU 2016 Videos